D81.4 Nezelof's syndrome

Name of the Condition

• Nezelof's syndrome

Summary

Nezelof's syndrome is a rare inherited immunodeficiency disorder characterized by impaired T-cell function, leading to increased susceptibility to infections. This condition results from genetic mutations that disrupt the development or function of T lymphocytes, compromising the body's ability to mount effective cellular immune responses. While B-cell numbers may be normal, antibody production is often inadequate due to T-cell dysfunction, contributing to a combined immunodeficiency phenotype.

Causes

Nezelof's syndrome is caused by genetic mutations affecting genes involved in T-cell development or function. These mutations disrupt signaling pathways, cell maturation, or enzyme activity essential for lymphocyte production. Inheritance is typically autosomal recessive, though specific genetic mechanisms may vary. The condition arises from errors in DNA that impair the body's ability to generate functional T cells, leading to defective cellular immunity.

Risk Factors

• Genetic predisposition, often with a family history of immunodeficiency disorders.
• Consanguinity (parents who are closely related) increasing the risk of autosomal recessive forms.
• Certain ethnic backgrounds with higher prevalence of specific genetic mutations.

Symptoms

• Recurrent, severe, or persistent infections (e.g., bacterial, viral, fungal).
• Chronic or opportunistic infections due to impaired T-cell immunity.
• Failure to thrive or delayed growth in infants and children.
• Diarrhea or gastrointestinal issues from infectious causes.
• Skin rashes or lesions from viral or fungal infections.

Diagnosis

Diagnosis involves clinical evaluation of recurrent infections and immune function testing. Laboratory tests typically show reduced T-cell counts or function, with normal or elevated B-cell numbers and variable antibody levels. Genetic testing may identify specific mutations. Additional assessments include immunophenotyping, lymphocyte proliferation assays, and exclusion of other immunodeficiency disorders. Imaging or biopsies may be used to evaluate infection-related complications.

Treatment Options

Treatment focuses on managing infections and supporting immune function. Antibiotics, antivirals, or antifungals are used to treat active infections. Immunoglobulin replacement therapy may be administered to address antibody deficiencies. Hematopoietic stem cell transplantation (HSCT) is the only curative option for some patients, aiming to restore T-cell function. Supportive care includes prophylactic medications and monitoring for complications.

Prognosis and Follow-Up

Prognosis varies depending on the severity of immune dysfunction and response to treatment. Early diagnosis and HSCT can improve outcomes, but infections remain a significant risk. Regular follow-up with immunologists is essential to monitor immune function, manage infections, and adjust therapies. Lifelong surveillance for complications, such as autoimmune disorders or malignancies, may be necessary.

Complications

• Severe or life-threatening infections (e.g., pneumonia, sepsis).
• Chronic lung disease from recurrent respiratory infections.
• Autoimmune disorders due to immune dysregulation.
• Failure to thrive or developmental delays in children.
• Increased risk of certain cancers, such as lymphomas.

Lifestyle & Prevention

• Practice strict hygiene to reduce infection risk (e.g., handwashing, avoiding sick contacts).
• Ensure up-to-date vaccinations (where appropriate and safe).
• Avoid live vaccines in severely immunocompromised individuals.
• Maintain a balanced diet to support overall health.
• Promptly address any signs of infection to prevent progression.

When to Seek Professional Help

Seek immediate medical attention for:

• High fever or signs of severe infection (e.g., difficulty breathing, confusion).
• Persistent or worsening symptoms despite treatment.
• Unexplained weight loss or failure to thrive in children.
• New or unusual rashes, lesions, or skin changes.

Tips for Medical Coders

Document the specific immunological findings, including T-cell function tests and genetic results, to support the diagnosis. Note the presence of recurrent infections or complications, as these may influence coding specificity. Ensure documentation aligns with clinical criteria for Nezelof's syndrome, including the underlying immunodeficiency mechanism. Verify that the code D81.4 is used only when the condition is clinically confirmed and differentiated from other immunodeficiencies.